Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
Status:
Terminated
Trial end date:
2018-04-04
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the noninferiority of inhaled loxapine
compared to intramuscular haloperidol/lorazepam on agitation reduction at 120 minutes.